BV combines an anti-CD30 antibody with the cytotoxic agent monomethyl auristatin E (MMAE), delivering this potent drug directly to CD30-expressing lymphoma cells, inducing apoptosis [61,62,63]. The gene discussed is TNFRSF8; the disease is lymphoma.